全文获取类型
收费全文 | 7529篇 |
免费 | 513篇 |
国内免费 | 35篇 |
专业分类
耳鼻咽喉 | 50篇 |
儿科学 | 230篇 |
妇产科学 | 97篇 |
基础医学 | 793篇 |
口腔科学 | 220篇 |
临床医学 | 454篇 |
内科学 | 1864篇 |
皮肤病学 | 302篇 |
神经病学 | 508篇 |
特种医学 | 302篇 |
外科学 | 1569篇 |
综合类 | 56篇 |
现状与发展 | 1篇 |
预防医学 | 199篇 |
眼科学 | 81篇 |
药学 | 451篇 |
中国医学 | 9篇 |
肿瘤学 | 891篇 |
出版年
2023年 | 69篇 |
2022年 | 129篇 |
2021年 | 250篇 |
2020年 | 152篇 |
2019年 | 204篇 |
2018年 | 225篇 |
2017年 | 198篇 |
2016年 | 184篇 |
2015年 | 189篇 |
2014年 | 235篇 |
2013年 | 280篇 |
2012年 | 435篇 |
2011年 | 471篇 |
2010年 | 242篇 |
2009年 | 177篇 |
2008年 | 326篇 |
2007年 | 337篇 |
2006年 | 347篇 |
2005年 | 343篇 |
2004年 | 292篇 |
2003年 | 314篇 |
2002年 | 283篇 |
2001年 | 191篇 |
2000年 | 183篇 |
1999年 | 160篇 |
1998年 | 76篇 |
1997年 | 72篇 |
1996年 | 56篇 |
1995年 | 62篇 |
1994年 | 47篇 |
1993年 | 40篇 |
1992年 | 122篇 |
1991年 | 116篇 |
1990年 | 144篇 |
1989年 | 112篇 |
1988年 | 127篇 |
1987年 | 139篇 |
1986年 | 118篇 |
1985年 | 125篇 |
1984年 | 81篇 |
1983年 | 58篇 |
1981年 | 23篇 |
1979年 | 40篇 |
1978年 | 28篇 |
1977年 | 21篇 |
1975年 | 22篇 |
1974年 | 22篇 |
1971年 | 28篇 |
1968年 | 22篇 |
1966年 | 24篇 |
排序方式: 共有8077条查询结果,搜索用时 15 毫秒
991.
992.
Three-dimensional computed tomography angiography (3D-CTA) is valuable for preoperative simulations for lung cancer. However, when using 3D-CTA alone, it is difficult to identify tumor safety margins, especially for a segmentectomy. We report 2 cases of primary lung cancer for which we performed segmentectomy based on preoperative simulations by 3D-CTA with virtual 3D safety margins. We found this technique easy to use for simulations and useful for safely performing segmentectomy for small tumors in lung cancer. 相似文献
993.
994.
995.
K Matsushita K Uchida S Saigusa S Ide K Hashimoto Y Koike K Otake M Inoue K Tanaka M Kusunoki 《Journal of pediatric surgery》2012,47(7):1323-1330
Background/PurposeIncreased glycolysis is among the biochemical characteristics of cancerous tissue. The glucose transporter isoform 1 (GLUT1) gene encodes a key factor for glucose transport into cancerous tissue. However, the expression and functional significance of GLUT1 in neuroblastoma have not been fully characterized. Therefore, we investigated the association of GLUT1 expression with clinical outcomes in patients with neuroblastoma using immunohistochemical staining for GLUT1 in neuroblastoma tissues. We also assessed the efficacy of glycolysis inhibition as an anticancer treatment in neuroblastoma cell lines with altered expression of GLUT1.MethodsWe obtained total RNA from cancerous tissue by microdissection in 47 patients with neuroblastoma. GLUT1 expression levels were evaluated by quantitative real-time polymerase chain reaction. We analyzed the association of GLUT1 expression levels with clinical outcomes. We also examined changes in GLUT1 expression and proliferative responses in vitro using 4 neuroblastoma cell lines treated with a glycolysis inhibitor, 3-Bromopyruvate acid.ResultsElevated GLUT1 expression was associated with poor prognosis. Moreover, elevated GLUT1 expression independently predicted overall survival. Immunohistochemical analysis showed that GLUT1 expression tended to be localized to the centers of neuroblastoma cell nests. Our in vitro studies showed that 3-Bromopyruvate acid significantly suppressed the proliferation of neuroblastoma cells with high GLUT1 gene expression compared with those with low expression.ConclusionGlycolysis inhibitors are a potential therapeutic option for treating aggressive tumors expressing GLUT1. 相似文献
996.
Sekiya I Ojima M Suzuki S Yamaga M Horie M Koga H Tsuji K Miyaguchi K Ogishima S Tanaka H Muneta T 《Journal of orthopaedic research》2012,30(6):943-949
We investigated whether mesenchymal stem cells (MSCs) in synovial fluid (SF) increased in the knee with degenerated cartilage and osteoarthritis. SF was obtained from the knee joints of 22 patients with anterior cruciate ligament (ACL) injury during ACL reconstruction, and cartilage degeneration was evaluated arthroscopically. SF was also obtained from the knee joints of 6 healthy volunteers, 20 patients with mild osteoarthritis, and 26 patients with severe osteoarthritis, in which the grading was evaluated radiographically. The cell component in the SF was cultured for analyses. Synovium (SYN) and bone marrow (BM) were also harvested during total knee arthroplasties. The MSC number in SF was correlated with the cartilage degeneration score evaluated by arthroscopy. The MSC number in the SF was hardly noticed in normal volunteers, but it increased in accordance with the grading of osteoarthritis. Though no significant differences were observed regarding surface epitopes, or differentiation potentials, the morphology and gene profiles in SF MSCs were more similar to those in SYN MSCs than in BM MSCs. We listed 20 genes which were expressed higher in both SYN MSCs and SF MSCs than in BM MSCs, and 3 genes were confirmed by quantitative RT-PCR. MSCs in SF increased along with degenerated cartilage and osteoarthritis. 相似文献
997.
Hori T Ogura Y Ogawa K Kaido T Segawa H Okajima H Kogure T Uemoto S 《Clinical transplantation》2012,26(3):E324-E334
Small-for-size grafts are an issue in liver transplantation. Portal venous pressure (PVP) was monitored and intentionally controlled during living-donor liver transplantation (LDLT) in 155 adult recipients. The indocyanine green elimination rate (kICG) was simultaneously measured in 16 recipients and divided by the graft weight (g) to reflect portal venous flow (PVF). The target PVP was <20 mmHg. Patients were divided by the final PVP (mmHg): Group A, PVP < 12; Group B, 12 ≤ PVP < 15; Group C, 15 ≤ PVP < 20; and Group D, PVP ≥ 20. With intentional PVP control, we performed splenectomy and collateral ligation in 80 cases, splenectomy in 39 cases, and splenectomy, collateral ligation, and additional creation in five cases. Thirty-one cases received no modulation. Groups A and B showed good LDLT results, while Groups C and D did not. Final PVP was the most important factor for the LDLT results, and the PVP cutoffs for good outcomes and clinical courses were both 15.5 mmHg. The respective kICG/graft weight cutoffs were 3.5580 × 10(-4) /g and 4.0015 × 10(-4) /g. Intentional PVP modulation at <15 mmHg is a sure surgical strategy for small-for-size grafts, to establish greater donor safety with good LDLT results. The kICG/graft weight value may have potential as a parameter for optimal PVF and a predictor for LDLT results. 相似文献
998.
Many surgical treatments for moyamoya disease have been developed over the past 40 years. The optimum treatment for ischemic-type moyamoya disease is almost established. The first surgical treatment for the disease was the superficial temporal artery to middle carotid artery (STA-MCA) anastomosis. The discovery of spontaneous collateral formation following the STA-MCA anastomosis surgery led to the development of various indirect bypass procedures. Collateral formation and clinical outcomes from direct and indirect procedures have been compared to assess the merits and limitations of each technique. Experience and a greater understanding of the surgical effects of moyamoya disease have led to the development of surgical procedures combining various direct and indirect bypass techniques for optimal restoration of perfusion. This review of the historical development and efficacy of each procedure will aid surgeons in selecting the most appropriate surgical procedure for patients of different ages with different symptoms and disease severities. 相似文献
999.
We sought to clarify the controversial issue of whether detecting low‐level anti‐donor‐specific HLA antibody (HLA‐DSA) by single‐antigen flow‐bead assay (SAFB) may have a potential role in reducing acute and chronic antibody‐mediated rejection (AMR). We retrospectively studied the preoperative serum of ABO‐compatible living kidney transplantation recipients transplanted between 2001 and 2004 by SAFB using a Luminex platform. HLA‐DSA was detected only by SAFB in 24 patients, although all of them showed negative T‐cell and B‐cell complement‐dependent cytotoxicity (CDC) crossmatches. The HLA‐DSA patients went on to have surprisingly high levels of acute and chronic AMR despite being only weakly sensitized (acute AMR, 33.3%; chronic AMR, 41.7%). After 2005, we implemented SAFB routinely and any patient having a positive HLA‐DSA was considered to be a desensitization candidate. The 52 patients found to have HLA‐DSA underwent kidney transplantation after prior treatment with a single dose of rituximab (RIT) and three or four sessions of double‐filtration plasmapheresis (DFPP) in addition to regimens commonly used between 2001 and 2004. After 2005, there was a significant reduction in the occurrence of acute and chronic AMR (acute AMR, 4.7%, P < 0.001; chronic AMR, 4.7%, P < 0.001). The 5‐year graft survival rate also improved after implementing SAFB (83.3–98.1%, P = 0.032). The RIT/DFPP‐induction protocol may improve graft survival even in patients with low‐level DSA. 相似文献
1000.